GCIBritish Honey Company, Paul Hill and Alan Green
If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: British Honey Company, Paul Hill and Alan Green
Michael Williams, Chief Executive Officer of British Honey Company (BHC) talks about the business and its strategy on its first day of listing on the NEX Exchange.
The British Honey Company is a UK based producer of spirits, honey and jams. It began trading in November 2014 initially focused on honey production and, later, expanding into honey infused spirits. The Company currently produces 13 honey products and 16 spirits including gin, vodka, rum and whiskey, many of which have won awards in the UK and abroad. These products are produced and stored in the Company’s facilities in Worminghall Buckinghamshire.
Paul Hill, full time investor and analyst give his view on the market and what he's been buying and selling. We also mention the following companies:
Lloyds (LLOY)
Inspiration Healthcare Group (IHC)
Tristel (TSTL)
(Interview starts at 12 minutes 2 seconds)
Alan Green CEO of Brand Communications talks about:
Tiziana Life Science (TILS)
Destiny Pharma (DEST)
Open Open (ORPH)
Cadence Minerals (KDNC)
(Interview starts at 35 minutes 45 seconds)
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.